skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: EZB Electronic Journals Library remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy
Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy

Meissner, Eric G ; Decalf, Jérémie ; Casrouge, Armanda ; Masur, Henry ; Kottilil, Shyam ; Albert, Matthew L ; Duffy, Darragh Polyak, Stephen J

PloS one, 2015-07, Vol.10 (7), p.e0133236-e0133236 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
2
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

Romero, Ana I ; Lagging, Martin ; Westin, Johan ; Dhillon, Amar P ; Dustin, Lynn B ; Pawlotsky, Jean-Michel ; Neumann, Avidan U ; Ferrari, Carlo ; Missale, Gabriele ; Haagmans, Bart L ; Schalm, Solko W ; Zeuzem, Stefan ; Negro, Francesco ; Verheij-Hart, Elke ; Hellstrand, Kristoffer

The Journal of infectious diseases, 2006-10, Vol.194 (7), p.895-903 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system
Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system
Material Type:
Artigo 		Adicionar ao Meu Espaço

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

Lavie, Muriel ; Voisset, Cécile ; Vu‐Dac, Ngoc ; Zurawski, Virginie ; Duverlie, Gilles ; Wychowski, Czeslaw ; Dubuisson, Jean

Hepatology (Baltimore, Md.), 2006-12, Vol.44 (6), p.1626-1634 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Naggie, Susanna ; Cooper, Curtis ; Saag, Michael ; Workowski, Kimberly ; Ruane, Peter ; Towner, William J ; Marks, Kristen ; Luetkemeyer, Anne ; Baden, Rachel P ; Sax, Paul E ; Gane, Edward ; Santana-Bagur, Jorge ; Stamm, Luisa M ; Yang, Jenny C ; German, Polina ; Dvory-Sobol, Hadas ; Ni, Liyun ; Pang, Phillip S ; McHutchison, John G ; Stedman, Catherine A.M ; Morales-Ramirez, Javier O ; Bräu, Norbert ; Jayaweera, Dushyantha ; Colson, Amy E ; Tebas, Pablo ; Wong, David K ; Dieterich, Douglas ; Sulkowski, Mark

The New England journal of medicine, 2015-08, Vol.373 (8), p.705-713 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

Wyles, David L ; Ruane, Peter J ; Sulkowski, Mark S ; Dieterich, Douglas ; Luetkemeyer, Anne ; Morgan, Timothy R ; Sherman, Kenneth E ; Dretler, Robin ; Fishbein, Dawn ; Gathe, Joseph C ; Henn, Sarah ; Hinestrosa, Federico ; Huynh, Charles ; McDonald, Cheryl ; Mills, Anthony ; Overton, Edgar Turner ; Ramgopal, Moti ; Rashbaum, Bruce ; Ray, Graham ; Scarsella, Anthony ; Yozviak, Joseph ; McPhee, Fiona ; Liu, Zhaohui ; Hughes, Eric ; Yin, Philip D ; Noviello, Stephanie ; Ackerman, Peter

The New England journal of medicine, 2015-08, Vol.373 (8), p.714-725 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
6
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir
Material Type:
Artigo 		Adicionar ao Meu Espaço

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Ng, Teresa I ; Krishnan, Preethi ; Pilot-Matias, Tami ; Kati, Warren ; Schnell, Gretja ; Beyer, Jill ; Reisch, Thomas ; Lu, Liangjun ; Dekhtyar, Tatyana ; Irvin, Michelle ; Tripathi, Rakesh ; Maring, Clarence ; Randolph, John T ; Wagner, Rolf ; Collins, Christine

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível

Citações Citado por
7
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

Bourlière, Marc ; Gordon, Stuart C ; Flamm, Steven L ; Cooper, Curtis L ; Ramji, Alnoor ; Tong, Myron ; Ravendhran, Natarajan ; Vierling, John M ; Tran, Tram T ; Pianko, Stephen ; Bansal, Meena B ; de Lédinghen, Victor ; Hyland, Robert H ; Stamm, Luisa M ; Dvory-Sobol, Hadas ; Svarovskaia, Evguenia ; Zhang, Jie ; Huang, K.C ; Subramanian, G. Mani ; Brainard, Diana M ; McHutchison, John G ; Verna, Elizabeth C ; Buggisch, Peter ; Landis, Charles S ; Younes, Ziad H ; Curry, Michael P ; Strasser, Simone I ; Schiff, Eugene R ; Reddy, K. Rajender ; Manns, Michael P ; Kowdley, Kris V ; Zeuzem, Stefan

The New England journal of medicine, 2017-06, Vol.376 (22), p.2134-2146 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Sulkowski, Mark S ; Gardiner, David F ; Rodriguez-Torres, Maribel ; Reddy, K. Rajender ; Hassanein, Tarek ; Jacobson, Ira ; Lawitz, Eric ; Lok, Anna S ; Hinestrosa, Federico ; Thuluvath, Paul J ; Schwartz, Howard ; Nelson, David R ; Everson, Gregory T ; Eley, Timothy ; Wind-Rotolo, Megan ; Huang, Shu-Pang ; Gao, Min ; Hernandez, Dennis ; McPhee, Fiona ; Sherman, Diane ; Hindes, Robert ; Symonds, William ; Pasquinelli, Claudio ; Grasela, Dennis M

The New England journal of medicine, 2014-01, Vol.370 (3), p.211-221 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
Treatment of Hepatitis C: A Systematic Review
Treatment of Hepatitis C: A Systematic Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of Hepatitis C: A Systematic Review

Kohli, Anita ; Shaffer, Ashton ; Sherman, Amy ; Kottilil, Shyam

JAMA : the journal of the American Medical Association, 2014-08, Vol.312 (6), p.631-640 [Periódico revisado por pares]

Chicago, IL: American Medical Association

Texto completo disponível

Citações Citado por
10
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
Material Type:
Artigo 		Adicionar ao Meu Espaço

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

Guedj, Jeremie ; Dahari, Harel ; Rong, Libin ; Sansone, Natasha D. ; Nettles, Richard E. ; Cotler, Scott J. ; Layden, Thomas J. ; Uprichard, Susan L. ; Perelson, Alan S.

Proceedings of the National Academy of Sciences - PNAS, 2013-03, Vol.110 (10), p.3991-3996 [Periódico revisado por pares]

United States: National Academy of Sciences

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (3.375)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (3.669)
  2. magazinearticle  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (64)
  2. 1998Até2003  (251)
  3. 2004Até2009  (736)
  4. 2010Até2016  (1.792)
  5. Após 2016  (829)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (3.612)
  2. Japonês  (725)
  3. Espanhol  (35)
  4. Português  (28)
  5. Francês  (7)
  6. Coreano  (6)
  7. Hebraico  (4)
  8. Russo  (3)
  9. Holandês  (3)
  10. Serbian  (2)
  11. Norueguês  (2)
  12. Polonês  (2)
  13. Chinês  (2)
  14. Alemão  (2)
  15. Italiano  (1)
  16. Turco  (1)
  17. Islândico  (1)
  18. Sueco  (1)
  19. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.